| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/02/2010 | EP2192130A1 Human DR4 antibodies and uses thereof |
| 06/02/2010 | EP2192129A1 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 06/02/2010 | EP2192128A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/02/2010 | EP2192127A1 Haemophilus influenzae type IV Pili |
| 06/02/2010 | EP2191845A1 Immunology significant herpes simplex virus antigens and methods for using same |
| 06/02/2010 | EP2191844A1 Injectable vaccines against multiple meningococcal serogroups |
| 06/02/2010 | EP2190997A1 Late blight resistance gene from wild potato |
| 06/02/2010 | EP2190996A1 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 06/02/2010 | EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 06/02/2010 | EP2190989A1 Method for manufacturing a modified peptide |
| 06/02/2010 | EP2190984A2 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 06/02/2010 | EP2190978A2 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 06/02/2010 | EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 06/02/2010 | EP2190874A1 Insulin-like growth factor fusion proteins |
| 06/02/2010 | EP2190873A1 Truncated glp-1 derivatives and their therapeutical use |
| 06/02/2010 | EP2190872A1 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 06/02/2010 | EP2190871A1 Improved derivatives of amylin |
| 06/02/2010 | EP2190870A1 Cell marker of melanocyte cell lineage and uses thereof |
| 06/02/2010 | EP2190869A1 Method for prolonging longevity |
| 06/02/2010 | EP2190868A2 Methods of inhibiting calcineurin with apoe analogs |
| 06/02/2010 | EP2190867A1 Method for the stabilisation of purified p-glycoprotein |
| 06/02/2010 | EP2190866A2 Kappa-carrageenase and kappa-carrageenase-containing compositions |
| 06/02/2010 | EP2190865A1 Hypoallergenic molecules |
| 06/02/2010 | EP2190864A1 Protein |
| 06/02/2010 | EP2190863A2 New albumin binding compositions, methods and uses |
| 06/02/2010 | EP2190861A2 Activatable binding polypeptides and methods of identification and use thereof |
| 06/02/2010 | EP2190857A1 Glycoproteins and glycosylated cells and a method for the preparation of the same |
| 06/02/2010 | EP2190856A2 Polypeptides with modified amino acids |
| 06/02/2010 | EP2190486A2 A process for isolation and purification of a target protein free of prion protein (prpsc) |
| 06/02/2010 | EP2190485A1 Method for reducing the number of viruses and microorganisms in biological extracts containing solids, and extracts produced according to this method |
| 06/02/2010 | EP2190483A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 06/02/2010 | EP2190473A2 Peptide with reduced dimer formation |
| 06/02/2010 | EP2190455A1 Agents with angiogenic and wound healing activity |
| 06/02/2010 | EP2190448A2 Methods and uses thereof of prosaposin |
| 06/02/2010 | EP2190446A1 Novel insect cadherin fragments |
| 06/02/2010 | EP2190296A2 Process |
| 06/02/2010 | EP2190292A1 ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF |
| 06/02/2010 | EP1949913B1 Immunostimulatory combination for the prophylactics and treatment of hepatitis c |
| 06/02/2010 | EP1768697B1 Recombinant rabies virus compositions |
| 06/02/2010 | EP1723243B1 Plants having improved seed yield and method for making the same |
| 06/02/2010 | EP1539970B1 Seed-associated promoter sequences |
| 06/02/2010 | EP1539812B1 Osteoinductive biomaterials |
| 06/02/2010 | EP1534736B1 Nogo receptor antagonists |
| 06/02/2010 | EP1449432B1 Nonhuman model animal of systemic lupus erythematosus |
| 06/02/2010 | EP1306005B1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 06/02/2010 | EP1301146B1 Artificial vascular grafts and methods of producing and using same |
| 06/02/2010 | EP1265480B1 Chimeric animal model susceptible to human hepatitis c virus infection |
| 06/02/2010 | EP1066050B2 Application of hsp70 proteins |
| 06/02/2010 | DE69224660C5 Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen Means for modulating process by retinoid receptors and for useful links |
| 06/02/2010 | DE112008001730T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation |
| 06/02/2010 | CN1902218B Yeast strains with improved fructose fermentation capacity |
| 06/02/2010 | CN1840656B Methods to culture circovirus |
| 06/02/2010 | CN1800385B Hybrid expression of neisserial proteins |
| 06/02/2010 | CN1659180B Novel recombinant anticoagulant proteins |
| 06/02/2010 | CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/02/2010 | CN1291231B Human telomerase catalytic subunit |
| 06/02/2010 | CN101720332A Fsh producing cell clone |
| 06/02/2010 | CN101720331A Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 06/02/2010 | CN101717804A Method for preparing medical III type collagen |
| 06/02/2010 | CN101717759A Method for improving biological macromolecule crystallization condition screening success rate by using drying agent |
| 06/02/2010 | CN101717444A Kit for detecting melamine and application thereof |
| 06/02/2010 | CN101717443A Bensulfuron-methyl artificial immunogen BE-BSA, preparation thereof and application thereof |
| 06/02/2010 | CN101717442A Polyethylene glycol recombination DesB30 human insulin, preparation method and application thereof |
| 06/02/2010 | CN101717441A Venin-sourced demulcent CTXn, and purification method and applications thereof |
| 06/02/2010 | CN101717440A Method for preparing casein |
| 06/02/2010 | CN101717439A Venin-derived cytotoxin CTXn for drug rehabilitation and purification method and application thereof |
| 06/02/2010 | CN101717438A Method for extracting leaf protein of sweet potato vine |
| 06/02/2010 | CN101717437A Bacillus thuringiensis Cry9E gene, protein and applications thereof |
| 06/02/2010 | CN101717436A Mud crab bicistronic mRNA virus structural protein 2 and monoclonal antibody thereof and application |
| 06/02/2010 | CN101717435A Mud crab bicistronic mRNA virus structural protein 3, monoclonal antibody thereof and application |
| 06/02/2010 | CN101717434A Mud crab bicistronic mRNA virus structural protein 1, monoclonal antibody thereof and application |
| 06/02/2010 | CN101717433A Polypeptide immunogen, preparation method and application thereof |
| 06/02/2010 | CN101717432A Polyglutamic acid and application thereof in processing medicine, cosmetics, food and water |
| 06/02/2010 | CN101717349A Preparation method and applications of intermediate modifier of Sudan red I |
| 06/02/2010 | CN101338316B Gene BrARGOS for controlling organ sizes of Chinese cabbage and use thereof |
| 06/02/2010 | CN101338314B Recombined chicken alpha interferon gene and recombinant vector thereof |
| 06/02/2010 | CN101307315B Method for expressing growth factor of human blood vessel in bombyx mori by Bac-to-Bac system |
| 06/02/2010 | CN101250526B Y gene sequence of benzene induced aplastic anemia related antigen specific TCR V alpha 19 |
| 06/02/2010 | CN101215733B Collagen-base PEG composite fibre and spinning technique thereof |
| 06/02/2010 | CN101210246B Tea geometrid nerve synaptic vesicle protein gene svp and application thereof |
| 06/02/2010 | CN101200726B Monosomic addition line M14 in sugarbeet strain small gtpase gene |
| 06/02/2010 | CN101186644B H3 type flu virus hemagglutinin space conformation simulation antigen epitope and application thereof |
| 06/02/2010 | CN101173286B Arabidopsis thaliana salt-tolerance gene SRAT2 and uses thereof |
| 06/02/2010 | CN101130573B Immune trait associated protein of pig, encoding gene and application of the same |
| 06/01/2010 | US7728194 Transgenic plants for use in enhanced food production in farming; mitochondrial gene transfer; increased storage stability |
| 06/01/2010 | US7728193 Phytochrome-interacting protein and a use thereof |
| 06/01/2010 | US7728191 Expession vector comprising nucleotide sequences which code and enhance prolamin polypeptide transcription and RNA interfereing sequence which decrease expression of preferential storage proteins in seeds |
| 06/01/2010 | US7728189 Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression |
| 06/01/2010 | US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection |
| 06/01/2010 | US7728116 Method of preparing an osteogenic protein fraction |
| 06/01/2010 | US7728114 Cluster of differentiation (CD3) specific monoclonal antibody for use in treatment and prevention of autoimmune and transplant disorders |
| 06/01/2010 | US7728111 Anti-p55 TNF receptor antibody |
| 06/01/2010 | US7728108 PRO1550 polypeptides |
| 06/01/2010 | US7728107 Canine 5-hydroxytryptamine 2A and 2B receptor |
| 06/01/2010 | US7728106 Amino acid fusion comprising oxazoline oligosaccharide for use as tool in treatment and prevention of viral infection; genetic vaccine; viricides |
| 06/01/2010 | US7728105 Peptides impairing PBX dependent gene regulation |
| 06/01/2010 | US7727960 Neutropenia; treating autoimmune diseases, acute inflammatory diseases, trauma, local inflammations, shock and burn |
| 06/01/2010 | US7727761 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 06/01/2010 | US7727732 Identifying regulatory agents for treatment and prevention of hyperproliferative or hypoproliferative disorders |
| 06/01/2010 | US7727729 Using taste specific g protein coupled receptors as tools in identifying modulator which can be used to customize taste in food and pharmaceuticals |